Amylyx Pharmaceuticals, Inc. (AMLX)
USD 5.32
(3.5%)
USD 5.32
(3.5%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 355.34 Million USD | 1747.2% |
| 2022 | 19.23 Million USD | 8156.22% |
| 2021 | 233 Thousand USD | 100.97% |
| 2020 | -23.94 Million USD | -128.63% |
| 2019 | -10.47 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | -8.64 Million USD | 69.2% |
| 2024 Q1 | -28.07 Million USD | -128.34% |
| 2023 Q3 | 97.47 Million USD | 5.22% |
| 2023 FY | 355.34 Million USD | 1747.2% |
| 2023 Q4 | 99.08 Million USD | 1.66% |
| 2023 Q2 | 92.63 Million USD | 40.05% |
| 2023 Q1 | 66.14 Million USD | 246.96% |
| 2022 Q2 | -105 Thousand USD | -200.0% |
| 2022 Q1 | -35 Thousand USD | -59.09% |
| 2022 FY | 19.23 Million USD | 8156.22% |
| 2022 Q4 | 19.06 Million USD | 10919.65% |
| 2022 Q3 | 173 Thousand USD | 264.76% |
| 2021 Q1 | -10 Thousand USD | 99.79% |
| 2021 FY | 233 Thousand USD | 100.97% |
| 2021 Q4 | -22 Thousand USD | 99.82% |
| 2021 Q3 | -12.56 Million USD | -125580.0% |
| 2021 Q2 | -10 Thousand USD | 0.0% |
| 2020 FY | -23.94 Million USD | -128.63% |
| 2020 Q4 | -4.66 Million USD | 0.0% |
| 2019 FY | -10.47 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Absci Corporation | -41.84 Million USD | 949.112% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | -275.141% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 76.589% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | 700425.187% |
| Apollomics, Inc. | 127 Thousand USD | -279699.213% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | 336362.124% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | 1545078.261% |
| Bicycle Therapeutics plc | -129.52 Million USD | 374.355% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -44207.357% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | -296020.833% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | -1672.117% |
| Chimerix, Inc. | 324 Thousand USD | -109574.383% |
| CRISPR Therapeutics AG | 240.95 Million USD | -47.473% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | -613.473% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | -758.612% |
| Fortress Biotech, Inc. | 57.85 Million USD | -514.221% |
| Fortress Biotech, Inc. | 57.85 Million USD | -514.221% |
| Gritstone bio, Inc. | -6.26 Million USD | 5776.438% |
| Allakos Inc. | -6.14 Million USD | 5886.435% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | 37231.139% |
| Cara Therapeutics, Inc. | 14.79 Million USD | -2301.953% |
| Cytokinetics, Incorporated | -322.59 Million USD | 210.153% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | 203154.286% |
| Innoviva, Inc. | 261.06 Million USD | -36.114% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 3114975.526% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | 10106.899% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | 3535519.361% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | 40434.279% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | 89158.897% |
| ImmuCell Corporation | 4.39 Million USD | -7982.849% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 434.843% |
| Incyte Corporation | 3.44 Billion USD | 89.672% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | 13401.189% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -182401.489% |
| Mustang Bio, Inc. | -2.22 Million USD | 16070.562% |
| MiMedx Group, Inc. | 266.84 Million USD | -33.166% |
| MEI Pharma, Inc. | 49.32 Million USD | -620.386% |
| MacroGenics, Inc. | 50.52 Million USD | -603.277% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Mereo BioPharma Group plc | 7.42 Million USD | -4685.147% |
| Marker Therapeutics, Inc. | -7.1 Million USD | 5100.875% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | -1123.008% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | -153.452% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | 1147040.159% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | 366435.052% |
| NextCure, Inc. | -3.68 Million USD | 9745.63% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | -13705.167% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -1766.014% |
| Onconetix, Inc. | -1.12 Million USD | 31625.553% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | 1326.681% |
| Opthea Limited | 21.72 Thousand USD | -1635926.703% |
| Ovid Therapeutics Inc. | -1.2 Million USD | 29592.149% |
| Psyence Biomedical Ltd. | -240.00 USD | 148060516.667% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | 619967.076% |
| Precigen, Inc. | 106 Thousand USD | -335131.132% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | -35117.542% |
| Prime Medicine, Inc. | -147.9 Million USD | 340.252% |
| PureTech Health plc | -1.6 Million USD | 22267.498% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | 5106.269% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 96.856% |
| Replimune Group, Inc. | -2.65 Million USD | 13483.992% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 1418699.545% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | -223.712% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | 68865.893% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 188.911% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Sesen Bio, Inc. | 40 Million USD | -788.363% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | 883.993% |
| Solid Biosciences Inc. | -76.56 Million USD | 564.121% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | 2961308.333% |
| SciSparc Ltd. | 2.19 Million USD | -16081.466% |
| Sutro Biopharma, Inc. | -26.69 Million USD | 1431.179% |
| TG Therapeutics, Inc. | 219.1 Million USD | -62.178% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | -11639.181% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | 20652.053% |
| Travere Therapeutics, Inc. | 133.78 Million USD | -165.603% |
| UroGen Pharma Ltd. | 73.35 Million USD | -384.438% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | -8016.606% |
| XOMA Corporation | 3.86 Million USD | -9103.445% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | 25682.793% |
| AbCellera Biologics Inc. | 38.02 Million USD | -834.504% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | 7107000.0% |
| Cassava Sciences, Inc. | -89.42 Million USD | 497.375% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | 1240.108% |
| Precision BioSciences, Inc. | 40.47 Million USD | -778.002% |
| Dyadic International, Inc. | 922.95 Thousand USD | -38400.71% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | 241831.293% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | -1587.218% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -83707.783% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | 4190.538% |
| IGM Biosciences, Inc. | -211.66 Million USD | 267.885% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | 17902.856% |
| Acelyrin, Inc. | -115 Thousand USD | 309095.652% |
| Abeona Therapeutics Inc. | 2.43 Million USD | -14493.224% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | -196.732% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | 2760.196% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | -129.564% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 461.796% |
| Senti Biosciences, Inc. | -2.68 Million USD | 13344.316% |
| Mesoblast Limited | -9.81 Million USD | 3720.428% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 421.611% |
| ChromaDex Corporation | 50.78 Million USD | -599.774% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | -194.956% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Seer, Inc. | 7.02 Million USD | -4956.852% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | -162.695% |
| Novavax, Inc. | 639.93 Million USD | 44.472% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 461.995% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | 917.58% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -273242.308% |
| Celcuity Inc. | -142.77 Thousand USD | 248989.838% |
| ContextLogic Inc. | 59 Million USD | -502.28% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | -68899.029% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | -2043.603% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 89.544% |
| Amarin Corporation plc | 165.54 Million USD | -114.657% |
| AnaptysBio, Inc. | 14.78 Million USD | -2304.066% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | 62771.076% |
| Aptorum Group Limited | -1.11 Million USD | 31978.427% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | -1353.294% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | -47.608% |
| Ardelyx, Inc. | 106.66 Million USD | -233.154% |
| Celularity Inc. | 6.75 Million USD | -5160.474% |
| Omeros Corporation | -69.77 Million USD | 609.243% |
| Humacyte, Inc. | -76.55 Million USD | 564.2% |
| Immunocore Holdings plc | 248.39 Million USD | -43.059% |
| IO Biotech, Inc. | -756 Thousand USD | 47103.307% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Cabaletta Bio, Inc. | -1.42 Million USD | 25019.004% |
| Summit Therapeutics Inc. | -2.05 Million USD | 17433.902% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | 7506.107% |
| Pulmatrix, Inc. | -8.22 Million USD | 4422.932% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 189.105% |
| Evogene Ltd. | 1.39 Million USD | -25299.929% |
| CorMedix Inc. | -205.56 Thousand USD | 172965.121% |
| BioLineRx Ltd. | 1.1 Million USD | -31970.848% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | -71542.137% |
| Sagimet Biosciences Inc. | 2 Million USD | -17667.25% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 59.265% |
| scPharmaceuticals Inc. | 9.78 Million USD | -3532.642% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 615.023% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 25.331% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 3114975.526% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Akero Therapeutics, Inc. | -29 Thousand USD | 1225427.586% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | 188113.228% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | -8671.785% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | 67784.762% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | 804266.289% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | 3502.072% |
| Daré Bioscience, Inc. | 2.76 Million USD | -12730.553% |
| bluebird bio, Inc. | -4.03 Million USD | 8917.494% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 81.341% |
| DBV Technologies S.A. | 15.72 Million USD | -2159.315% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 295.882% |
| Galecto, Inc. | -830 Thousand USD | 42912.651% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | 62332.049% |
| Spruce Biosciences, Inc. | -39.34 Million USD | 1003.198% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | -58248.933% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | 248071.054% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | -550.589% |
| ADMA Biologics, Inc. | 88.21 Million USD | -302.803% |
| Clene Inc. | 533 Thousand USD | -66568.856% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | -17774.497% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | 74981.202% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | 3416878.846% |
| Soligenix, Inc. | 97.31 Thousand USD | -365064.267% |
| Century Therapeutics, Inc. | -10.8 Million USD | 3387.492% |
| Kura Oncology, Inc. | -849 Thousand USD | 41954.535% |
| Surrozen, Inc. | -27.23 Million USD | 1404.976% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 629.544% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | -258.793% |
| Autolus Therapeutics plc | -4.86 Million USD | 7401.11% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| Eterna Therapeutics Inc. | -168 Thousand USD | 211614.881% |
| Caribou Biosciences, Inc. | -77.59 Million USD | 557.931% |
| GRI Bio, Inc. | 10.84 Million USD | -3177.788% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -13890.038% |
| Janux Therapeutics, Inc. | -46.83 Million USD | 858.652% |
| INmune Bio, Inc. | 155 Thousand USD | -229154.839% |
| Heron Therapeutics, Inc. | 61.93 Million USD | -473.702% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 23690.727% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 54898.798% |
| Tenax Therapeutics, Inc. | -7570.00 USD | 4694221.532% |
| Jaguar Health, Inc. | 7.72 Million USD | -4500.531% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | 1213958.714% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | -88294.279% |
| Clearside Biomedical, Inc. | 7.87 Million USD | -4414.611% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | 113628.754% |
| Coherus BioSciences, Inc. | 94.46 Million USD | -276.182% |
| Verastem, Inc. | -62 Thousand USD | 573237.097% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | 136247.51% |
| Histogen Inc. | 3.76 Million USD | -9328.098% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | -61572.675% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 47.798% |
| Surrozen, Inc. | -27.23 Million USD | 1404.976% |
| Organovo Holdings, Inc. | -5.38 Million USD | 6693.895% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | 17946817.172% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | -5757.57% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | 529430.712% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -243620.85% |
| Kronos Bio, Inc. | 1.37 Million USD | -25799.781% |
| Turnstone Biologics Corp. | 16.5 Million USD | -2052.823% |
| Synaptogenix, Inc. | -6347.00 USD | 5598729.274% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | 696854.902% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | -1119.901% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | -120.212% |
| Exelixis, Inc. | 1.75 Billion USD | 79.783% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 416.817% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | -5.106% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 32170.848% |
| ESSA Pharma Inc. | -118.49 Thousand USD | 299991.975% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | -4755.766% |
| Insmed Incorporated | 239.63 Million USD | -48.286% |
| MediWound Ltd. | 3.57 Million USD | -9831.386% |
| OmniAb, Inc. | 14.66 Million USD | -2322.752% |
| Alector, Inc. | -95.05 Million USD | 473.839% |
| Seres Therapeutics, Inc. | 125.62 Million USD | -182.871% |
| Zai Lab Limited | 170.9 Million USD | -107.922% |
| AlloVir, Inc. | -398 Thousand USD | 89382.663% |
| Revance Therapeutics, Inc. | 81.87 Million USD | -333.999% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | 34532.655% |
| Aura Biosciences, Inc. | -1.29 Million USD | 27539.768% |
| Immunic, Inc. | -111 Thousand USD | 320230.631% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | -2141.359% |
| Veracyte, Inc. | 248.14 Million USD | -43.199% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 105.084% |
| FibroGen, Inc. | 128.9 Million USD | -175.666% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | -13.286% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | 63004532.624% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | 3145.757% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | -91248.329% |
| Fortrea Holdings Inc. | 424 Million USD | 16.192% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 512.391% |
| XBiotech Inc. | -1.74 Million USD | 20475.287% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 32170.848% |
| Keros Therapeutics, Inc. | -664 Thousand USD | 53615.813% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | 864.66% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 570.444% |
| Agenus Inc. | 139.61 Million USD | -154.518% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | -384.101% |
| Theravance Biopharma, Inc. | 16.8 Million USD | -2014.771% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | 8.661% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | 815.743% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | -8.751% |
| Gain Therapeutics, Inc. | -11.32 Million USD | 3238.025% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 466.524% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | -6580362.963% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | 531838.669% |
| Lantern Pharma Inc. | -174.84 Thousand USD | 203336.618% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | 95112.032% |
| Ainos, Inc. | -253.73 Thousand USD | 140146.821% |
| Pluri Inc. | 322 Thousand USD | -110255.59% |
| Prothena Corporation plc | -129.2 Million USD | 375.033% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | -604.715% |
| Rallybio Corporation | -150 Thousand USD | 236996.667% |
| Kodiak Sciences Inc. | -25.94 Million USD | 1469.503% |
| Cue Biopharma, Inc. | -32.6 Million USD | 1189.781% |
| MeiraGTx Holdings plc | 287 Thousand USD | -123713.589% |
| Annexon, Inc. | -3.26 Million USD | 10976.798% |
| Assembly Biosciences, Inc. | -41.73 Million USD | 951.391% |
| Moderna, Inc. | 2.15 Billion USD | 83.511% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | 2442.574% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | -469.627% |
| Blueprint Medicines Corporation | 236.58 Million USD | -50.198% |
| Immix Biopharma, Inc. | -5468.00 USD | 6498728.383% |
| CalciMedica, Inc. | -58 Thousand USD | 612763.793% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | 5811.106% |
| Scholar Rock Holding Corporation | -2.84 Million USD | 12594.55% |
| Wave Life Sciences Ltd. | 104.09 Million USD | -241.353% |
| Sana Biotechnology, Inc. | -30.86 Million USD | 1251.288% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | 30471.368% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | -12702.526% |
| Nutriband Inc. | 862.1 Thousand USD | -41118.297% |
| Protara Therapeutics, Inc. | -341 Thousand USD | 104306.745% |
| Vor Biopharma Inc. | -3.49 Million USD | 10275.974% |
| Roivant Sciences Ltd. | 109.23 Million USD | -225.303% |
| Alkermes plc | 1.37 Billion USD | 74.151% |
| ProKidney Corp. | -3.16 Million USD | 11313.159% |
| Applied Therapeutics, Inc. | -43.91 Million USD | 909.221% |
| Arcellx, Inc. | 108.27 Million USD | -228.175% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | -5082.223% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 551.685% |
| Galectin Therapeutics Inc. | -33 Thousand USD | 1076903.03% |
| Atai Life Sciences N.V. | -5000.00 USD | 7107000.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | 291703.41% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | 370251.042% |
| MediciNova, Inc. | 979.7 Thousand USD | -36170.612% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 521.429% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 375907.731% |
| GeoVax Labs, Inc. | -20.72 Million USD | 1814.922% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | -45.315% |
| Biomea Fusion, Inc. | -4.2 Million USD | 8558.581% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Cullinan Oncology, Inc. | -310 Thousand USD | 114727.419% |
| Geron Corporation | -123.5 Million USD | 387.722% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 7107000.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 565.276% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | 14539.049% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | -66.255% |
| Royalty Pharma plc | 1.79 Billion USD | 80.191% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | 37862.487% |
| Imunon, Inc. | -720 Thousand USD | 49453.129% |
| BioAtla, Inc. | -103.73 Million USD | 442.564% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 246.342% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | 114358.842% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 418.941% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | 37537.288% |
| 89bio, Inc. | -273 Thousand USD | 130263.004% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 607.02% |
| aTyr Pharma, Inc. | -2.38 Million USD | 14980.444% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | -2751.886% |
| Viridian Therapeutics, Inc. | -1 Million USD | 35352.48% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | -2733422976.923% |
| Akari Therapeutics, Plc | -4000.00 USD | 8883725.0% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 44.206% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | -31655.585% |
| Liquidia Corporation | 14.6 Million USD | -2333.87% |
| Entera Bio Ltd. | -56 Thousand USD | 634644.643% |
| GH Research PLC | -315 Thousand USD | 112907.937% |
| Vericel Corporation | 135.57 Million USD | -162.1% |
| Arbutus Biopharma Corporation | -55.55 Million USD | 739.581% |
| Xencor, Inc. | -85.26 Million USD | 516.778% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | 160906.328% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 54898.798% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | 35590.634% |
| Vaxcyte, Inc. | -75 Million USD | 573.793% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 312.131% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | -99.807% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -182401.489% |
| Portage Biotech Inc. | -54 Thousand USD | 658146.296% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 375907.731% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | 94355.968% |
| OncoCyte Corporation | 413 Thousand USD | -85939.952% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | 7905439.266% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | 160065415.315% |
| Purple Biotech Ltd. | -196 Thousand USD | 181398.469% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | 93366.404% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | 1716.16% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | -421.6% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | -3862.366% |
| Moleculin Biotech, Inc. | -127 Thousand USD | 279899.213% |
| United Therapeutics Corporation | 2.07 Billion USD | 82.834% |
| HilleVax, Inc. | -2.15 Million USD | 16581.679% |
| Silo Pharma, Inc. | 66.26 Thousand USD | -536156.489% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | 9114.223% |
| Pharming Group N.V. | 220.1 Million USD | -61.444% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | -15 Thousand USD | 2368435.111% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | 53295.359% |
| Pyxis Oncology, Inc. | -2 Million USD | 17867.25% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | -7506.16 USD | 4734145.104% |
| Savara Inc. | -44.26 Million USD | 902.822% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 433447.561% |
| Curis, Inc. | 9.81 Million USD | -3521.904% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | 284858.951% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | 155953.07% |
| BeiGene, Ltd. | 2.07 Billion USD | 82.907% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | -526.843% |
| Erasca, Inc. | -3.73 Million USD | 9621.57% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 1259384.854% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 1259384.854% |
| Vincerx Pharma, Inc. | -915 Thousand USD | 38935.519% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -4338.484% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | 66395.709% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 419.762% |
| Cogent Biosciences, Inc. | -3.58 Million USD | 10003.707% |
| Adicet Bio, Inc. | -6.09 Million USD | 5927.238% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | 1.847% |
| Aditxt, Inc. | -111.66 Thousand USD | 318338.402% |
| Adagene Inc. | 18.11 Million USD | -1861.986% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | -72716.598% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | -125.136% |
| Compugen Ltd. | 31.45 Million USD | -1029.693% |
| Generation Bio Co. | -73.91 Million USD | 580.774% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | 81414.645% |
| Invivyd, Inc. | -2.02 Million USD | 17621.943% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 218.117% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | 343634.291% |
| Spero Therapeutics, Inc. | 96.36 Million USD | -268.738% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | -261.534% |
| Instil Bio, Inc. | -4.75 Million USD | 7571.51% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | -1373.899% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -31219.519% |
| GeoVax Labs, Inc. | -20.72 Million USD | 1814.922% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | 182969.656% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | 42605.383% |
| Vir Biotechnology, Inc. | 83.41 Million USD | -325.997% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -485928.285% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | -568.419% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 305.179% |
| Tyra Biosciences, Inc. | -353 Thousand USD | 100764.306% |
| Cingulate Inc. | -582.91 Thousand USD | 61059.689% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | 1146374.194% |
| Unity Biotechnology, Inc. | -19.69 Million USD | 1903.873% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | 36066.093% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | 630792.911% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | 762.142% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | 121793.493% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | 67527.894% |
| ImmunityBio, Inc. | -17.89 Million USD | 2086.277% |
| Korro Bio, Inc. | -3.63 Million USD | 9889.118% |
| Kineta, Inc. | 5.43 Million USD | -6440.493% |
| BioVie Inc. | -229.37 Thousand USD | 155017.45% |
| Codexis, Inc. | 57.33 Million USD | -519.781% |
| Celularity Inc. | 6.75 Million USD | -5160.474% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | 298709.244% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -8754.847% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | -702301.66% |
| Cibus, Inc. | 1.42 Million USD | -24889.1% |
| IN8bio, Inc. | -2.5 Million USD | 14308.117% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | 17484.785% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -55422.656% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 54.356% |
| Eyenovia, Inc. | - USD | -Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | -105.455% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Elevation Oncology, Inc. | -39 Thousand USD | 911241.026% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | 18802.368% |
| Cardiff Oncology, Inc. | -32.36 Million USD | 1197.794% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | -348.645% |
| Regulus Therapeutics Inc. | -21.15 Million USD | 1779.959% |
| Moolec Science SA | -143.3 Thousand USD | 248064.132% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | 939.702% |
| LAVA Therapeutics N.V. | 3.28 Million USD | -10710.618% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 606.984% |
| Compass Therapeutics, Inc. | -1.89 Million USD | 18901.323% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | 9838001.44% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | -153469.067% |
| Humacyte, Inc. | -76.55 Million USD | 564.2% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | 28369.292% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | -848 Thousand USD | 42003.892% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | 288998.374% |
| Notable Labs, Ltd. | 113 Thousand USD | -314364.602% |
| Immunovant, Inc. | -231 Thousand USD | 153929.004% |
| Quantum-Si incorporated | 488 Thousand USD | -72716.598% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | 1184583.333% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -18984.049% |
| Acasti Pharma Inc. | -11 Thousand USD | 3230509.091% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | 173763.479% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | 18248.366% |
| PepGen Inc. | -1.18 Million USD | 30112.247% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | 1651.928% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | 430388.316% |
| Immuneering Corporation | -764.13 Thousand USD | 46602.726% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Belite Bio, Inc | -399 Thousand USD | 89158.897% |
| XOMA Corporation | 3.86 Million USD | -9103.445% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | 1873.533% |
| Bionomics Limited | -434.44 Thousand USD | 81892.109% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 33186.127% |
| uniQure N.V. | 2.21 Million USD | -15942.664% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 485.955% |
| Forte Biosciences, Inc. | -9000.00 USD | 3948377.778% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | 42656.287% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | 81414.645% |
| Altimmune, Inc. | -65.37 Million USD | 643.565% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | 14862.983% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 33186.127% |
| Peak Bio, Inc. | 367.76 Thousand USD | -96521.792% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | -1349.441% |
| Benitec Biopharma Inc. | 108 Thousand USD | -328923.148% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | 455670.513% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | 29638.238% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | -1.82 Million USD | 19603.019% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | 29638.238% |
| argenx SE | 1.1 Billion USD | 67.943% |
| Immunome, Inc. | -8.9 Million USD | 4089.503% |
| Verona Pharma plc | -679.62 Thousand USD | 52385.528% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | 203154.286% |
| Shattuck Labs, Inc. | -2.38 Million USD | 14999.161% |
| CervoMed Inc. | -1.29 Million USD | 27568.892% |
| Plus Therapeutics, Inc. | -4.77 Million USD | 7538.664% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | -14280.615% |
| Moolec Science SA | -143.3 Thousand USD | 248064.132% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | 87187.959% |
| Design Therapeutics, Inc. | -537 Thousand USD | 66272.253% |
| Leap Therapeutics, Inc. | -427 Thousand USD | 83318.97% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | -16458.481% |
| Achilles Therapeutics plc | -4.73 Million USD | 7610.567% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | 880.155% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | -826283.721% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | 43329.319% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | 2700700.395% |
| Tourmaline Bio, Inc. | -33 Thousand USD | 1076903.03% |
| Beam Therapeutics Inc. | -59.67 Million USD | 695.497% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | -155.029% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| Aadi Bioscience, Inc. | 21.54 Million USD | -1549.315% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | 119744.781% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | 8923.982% |
| NeurAxis, Inc. | 2.15 Million USD | -16376.299% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | 3814.667% |
| Lumos Pharma, Inc. | 2 Million USD | -17605.282% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | -1022.423% |
| Palisade Bio, Inc. | 246 Thousand USD | -144349.187% |
| Nutriband Inc. | 862.1 Thousand USD | -41118.297% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | -2423.757% |
| Neurogene Inc. | -3.26 Million USD | 10993.47% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | 646181.818% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | 9724.729% |
| Athira Pharma, Inc. | -969 Thousand USD | 36771.311% |
| HCW Biologics Inc. | -574.82 Thousand USD | 61918.052% |
| XOMA Corporation | 3.86 Million USD | -9103.445% |
| Nektar Therapeutics | 53.47 Million USD | -564.47% |
| Arvinas, Inc. | 71.8 Million USD | -394.909% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Merus N.V. | -83.46 Million USD | 525.762% |
| Omega Therapeutics, Inc. | -62.77 Million USD | 666.061% |
| Quince Therapeutics, Inc. | -322 Thousand USD | 110455.59% |
| Rezolute, Inc. | -36 Thousand USD | 987169.444% |
| Clene Inc. | 533 Thousand USD | -66568.856% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | 27674944.237% |
| BeyondSpring Inc. | 1.75 Million USD | -20193.832% |
| Synlogic, Inc. | -1.92 Million USD | 18569.075% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | 960491.892% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | 5711.892% |
| Peak Bio, Inc. | 367.76 Thousand USD | -96521.792% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | 1973.886% |
| Krystal Biotech, Inc. | 47.6 Million USD | -646.445% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | -151.855% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | -6971.542% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | 13824.023% |
| MannKind Corporation | 136.19 Million USD | -160.917% |
| Ikena Oncology, Inc. | -50.49 Million USD | 803.765% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | -226.562% |
| Gossamer Bio, Inc. | -4.38 Million USD | 8203.649% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | 141109.921% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 7107000.0% |
| Legend Biotech Corporation | 140.92 Million USD | -152.145% |
| Mural Oncology plc | -2.56 Million USD | 13942.813% |
| Disc Medicine, Inc. | -100 Thousand USD | 355445.0% |
| Champions Oncology, Inc. | 20.75 Million USD | -1612.176% |
| REGENXBIO Inc. | 53.02 Million USD | -570.096% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | 6733.342% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | 184814.75% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | 20616.455% |
| Vaxart, Inc. | -60.76 Million USD | 684.805% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | 135325.284% |
| Cellectis S.A. | 18 Thousand USD | -1974038.889% |
| Longeveron Inc. | 221 Thousand USD | -160689.593% |
| Repare Therapeutics Inc. | -80.07 Million USD | 543.793% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 67.489% |
| Inozyme Pharma, Inc. | -1.29 Million USD | 27560.974% |
| Revolution Medicines, Inc. | -399.66 Million USD | 188.911% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | 1015371.429% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | -725093.878% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 95.871% |
| Denali Therapeutics Inc. | -93.34 Million USD | 480.679% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 1418699.545% |
| Veru Inc. | 7.56 Million USD | -4596.648% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | 235427.815% |
| Cingulate Inc. | -582.91 Thousand USD | 61059.689% |
| Passage Bio, Inc. | -3.72 Million USD | 9649.718% |
| Context Therapeutics Inc. | -12.04 Thousand USD | 2950490.236% |
| Exicure, Inc. | -1.42 Million USD | 25071.539% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | 92879.373% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -13046.319% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | 69411.942% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | 237618.966% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | 700.184% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | -90781.074% |
| OmniAb, Inc. | 14.66 Million USD | -2322.752% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | -1677.347% |
| Lipocine Inc. | -2.85 Million USD | 12564.668% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | 19380.792% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | 6328.659% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 23690.727% |
| G1 Therapeutics, Inc. | 75.31 Million USD | -371.805% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | 546784.615% |
| Sage Therapeutics, Inc. | 84.29 Million USD | -321.544% |
| Ocugen, Inc. | -33.53 Million USD | 1159.561% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | 11337.982% |
| Q32 Bio Inc. | 578 Thousand USD | -61378.374% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | 134192.453% |
| Alumis Inc. Common Stock | -1.28 Million USD | 27774.844% |
| Equillium, Inc. | 35.95 Million USD | -888.222% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | 20916.93% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | -70872.619% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | 8595770.053% |
| Dominari Holdings Inc. | 2.03 Million USD | -17327.415% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | 193779.11% |
| vTv Therapeutics Inc. | -13.59 Million USD | 2713.792% |
| Bio-Techne Corporation | 773.07 Million USD | 54.035% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | -1951.764% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 22.883% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | 30497.348% |
| Candel Therapeutics, Inc. | -23.98 Million USD | 1581.839% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | -2937.916% |
| Nkarta, Inc. | -5.86 Million USD | 6154.609% |
| BioCardia, Inc. | -7.24 Million USD | 5001.986% |
| Iterum Therapeutics plc | -1.75 Million USD | 20405.429% |